Question 1

How many shares of TXG does CAPSTONE INVESTMENT ADVISORS, LLC own?

Accepted Answer

CAPSTONE INVESTMENT ADVISORS, LLC previously held 0 shares of TXG (10x Genomics Inc Class A) before exiting the position in 2025-Q4.

Question 2

What is CAPSTONE INVESTMENT ADVISORS, LLC's TXG position worth?

Accepted Answer

CAPSTONE INVESTMENT ADVISORS, LLC's TXG position was last reported at $0 in 2025-Q4 before the exit.

Question 3

Is CAPSTONE INVESTMENT ADVISORS, LLC buying or selling TXG?

Accepted Answer

In 2025-Q4, CAPSTONE INVESTMENT ADVISORS, LLC exited their TXG position entirely (-100.0% change in shares).

Question 4

When did CAPSTONE INVESTMENT ADVISORS, LLC first buy TXG?

Accepted Answer

Based on available 13F filings, CAPSTONE INVESTMENT ADVISORS, LLC first reported a position in TXG in 2024-Q3. They have held the position across 6 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$16.29	0
2025-Q3	New	29,776	—	$348,081	0.0%	$11.34	33
2024-Q3	Exited	0	-100.0%	$0	0.0%	$22.67	0